Unleashing the Power of Genomics: Understanding the Environment and Biological Diversity

Since The Institute for Genomic Research first decoded the complete genetic material of a free-living organism (Haemophilus influenzae) in 1995,1 we have seen an explosion in the number of completed genomes. The total completed genome count is about 150, a number that is likely to double in 2004. Next year, we will experience a greater shift in genomics, from simply obtaining the genetic code of organisms to comparing and interpreting them, eventually understanding how the four-letter (ACGT)

Written byCraig Venter
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Since The Institute for Genomic Research first decoded the complete genetic material of a free-living organism (Haemophilus influenzae) in 1995,1 we have seen an explosion in the number of completed genomes. The total completed genome count is about 150, a number that is likely to double in 2004.

Next year, we will experience a greater shift in genomics, from simply obtaining the genetic code of organisms to comparing and interpreting them, eventually understanding how the four-letter (ACGT) code leads to such diversity of life.

Mathematical, computational, and strategic advances, as well as new analytical instruments, have completely revolutionized genomics; more than 1,000 sequenced genomes should be finished by the end of 2005. These same tools are now being used to characterize and understand the environment. As a result, a new discipline is emerging: "environmental genomics." Through The Institute for Biological Energy Alternatives, we are expanding the environmental applications of genomics ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies